DFTX Definium Therapeutics, Inc.
Healthcare$22.50-0.66%ClosedMarket Cap: $2.45B
As of 2026-05-25
Insider Statistics (Q1 2026)
Acquisitions
6
Dispositions
3
Buy/Sell Ratio
2.00
Net Shares
+866,849
Shares Acquired
910,000
Shares Disposed
43,151
Total Bought ($)
$0.00
Total Sold ($)
$3.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Mar 26 | Sullivan Mark | officer: Chief Legal Officer | Sell | 10,702 | $18.47 | 271,079 |
| Thu Mar 26 | Karlin Daniel | officer: Chief Medical Officer | Sell | 8,018 | $18.47 | 413,317 |
| Thu Mar 26 | Barrow Robert | director, officer: Chief Executive Officer | Sell | 24,431 | $18.47 | 752,454 |
| Thu Feb 05 | Wiley Matthew T. | officer: Chief Commercial Officer | Sell | 115,000 | $0.00 | 115,000 |
| Thu Feb 05 | Sullivan Mark | officer: Chief Legal Officer | Sell | 125,000 | $0.00 | 407,576 |
| Thu Feb 05 | Roberts Brandi | officer: Chief Financial Officer | Sell | 150,000 | $0.00 | 150,000 |
| Thu Feb 05 | Karlin Daniel | officer: Chief Medical Officer | Sell | 150,000 | $0.00 | 575,025 |
| Thu Feb 05 | Barrow Robert | director, officer: Chief Executive Officer | Sell | 320,000 | $0.00 | 1,098,477 |
| Thu Jan 29 | Adsett Roger | director | Sell | 50,000 | $17.24 | 50,000 |
| Thu Jan 29 | Adsett Roger | Sell | 0 | $0.00 | 0 | |
| Mon Dec 29 | Sullivan Mark | officer: Chief Legal Officer | Sell | 11,276 | $13.15 | 282,576 |
| Mon Dec 29 | Karlin Daniel | officer: Chief Medical Officer | Sell | 5,600 | $13.15 | 425,025 |
| Mon Dec 29 | Barrow Robert | director, officer: Chief Executive Officer | Sell | 25,791 | $13.15 | 778,477 |